Anabolic steroids: What should the emergency physician know?

Emergency Medicine Clinics of North America

Volumn 23, Issue 3 SPEC. ISS., 2005, Pages 815-826

  Brown, James T ^a  

^a OSF SAINT FRANCIS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROCYP; DANAZOL; FLUOXYMESTERONE; METANDIENONE; NANDROLONE DECANOATE; NANDROLONE PHENPROPIONATE; OXANDROLONE; OXYMETHOLONE; STANOZOLOL; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE PROPIONATE;

ACNE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATHLETE; BONE TISSUE; BURN; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG ABUSE; EMERGENCY MEDICINE; ENDOCRINE DISEASE; HEMATOPOIESIS; HIRSUTISM; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; JAUNDICE; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MENSTRUATION DISORDER; MENTAL DISEASE; MUSCLE TISSUE; OVARY POLYCYSTIC DISEASE; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SPERMATOZOON ABNORMALITY;

EID: 20744439443     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2005.03.012     Document Type: Review

References (58)

1. E.C. Kutscher, B.C. Lund, and P.J. Perry Anabolic steroids: a review for the clinician Sports Med 32 5 2002 285 296
2. W.R. Yates, G.J. Perry, and K.H. Anderson Illicit anabolic steroid use: a controlled personality study Acta Psychiatr Scand 81 1990 548 550
3. Blue Cross and Blue Shield Association. Health Competition Foundation National survey on performance enhancing drugs in sports. Blue Cross and Blue Shield Association. URL: http://www.bcbs.com. 2001; Jan 1.
4. G.A. Green, F.D. Uryasz, and T.A. Petr NCAA study of substance use and misuse habits of college student-athletes Clin J Sport Med 11 2001 51 56
5. C.E. Yesalis, W.E. Buckley, and W.A. Anderson Athletes' projections of anabolic steroid use Clin Sports Med 2 1990 155 171
6. S. Basaria, J.T. Wahlstrom, and A.S. Dobs Anabolic-androgenic steroid therapy in the treatment of chronic diseases J Clin Endocrinol Metab 86 11 2001 5108 5117
7. W.M. Pardridge Serum bioavailability of sex steroid hormones Clin Endocrinol Metab 15 1986 259 287
8. F. Kadi, A. Eriksson, and S. Holmer Effects of anabolic steroids on the muscle cells of strength trained athletes Med Sci Sports Exerc 31 1999 1528 1534
9. M. Sheffield-Moore Androgens and the control of skeletal muscle protein synthesis Ann Med 32 2000 181 186
10. W.E. Buckley, C.E. Yesalis, and D.L. Bennell A study of anabolic steroid use at the secondary school level: recommendations for prevention C.E. Yesalis Anabolic steroids in sport and exercise 1993 Human Kinetics Publishing Champaign (IL) 71 86
11. F. Kadi Adaptation of human skeletal muscle to training and anabolic steroids Acta Physiol Scand Suppl 646 2000 1 52
12. J.E. Sturmi, and D.J. Kiorio Anabolic agents Clin Sports Med 17 1998 261 282
13. E. Creutzberg, and A. Schols Anabolic steroids Clin Nutr Metab 2 3 1999 243 253
14. I.M. Ferreira, I.T. Verreschi, and L.E. Nery The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients Chest 114 1998 19 28
15. I.F. Brodsky, P. Balagopal, and K.S. Nair Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - a clinical research center study J Clin Endocrinol Metab 81 1996 3469 3475
16. S. Bhasin, T.W. Storer, and N. Berman The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men N Engl J Med 335 1996 1 7
17. D. Vanderschueren, and S. Boonen Androgen exposure and the maintenance of skeletal integrity in aging men Aging Male 1 1998 180 187
18. R. Eastell, I.T. Boyle, J. Compston, and C. Cooper Management of male osteoporosis: report of the UK consensus Group Q J Med 91 1998 71 92
19. D.R. Lamb Anabolic steroids in athletics: how well do they work and how dangerous are they? Am J Sports Med 12 1984 31 38
20. R.C. Hickson, K.L. Ball, and M.T. Falduto Adverse effects of anabolic steroids Med Toxicol Adverse Drug Exp 4 1989 254 271
21. C.E. Yesalis, and M.S. Bahrke Anabolic-androgenic steroids: current issues Sports Med 19 1995 326 340
22. P.J. Perry, K.H. Anderson, and W.R. Yates Illicit anabolic steroid use in athletes: a case series analysis Am J Sports Med 18 1990 422 428
23. American Academy of Pediatrics Adolescents and anabolic steroids: a subject review Pediatrics 99 6 1997 904 908
24. D.M. Crist, P.J. Stackpole, and G.T. Peale Effects of androgenic-anabolic steroids on neuromuscular power and body composition J Appl Physiol 54 1983 366 370
25. G.R. Hervey, A.V. Knibbs, and L. Burkenshaw Effects of methandienone on the performance and body compostion of men undergoing athletic training Clin Sci 60 1981 457 461
26. K.G. Ishak, and H.J. Zimmerman Hepatotoxic effects of the anabolic/androgenic steroids Semin Liver Sis 7 1987 230 236
27. J.G. Blue, and J.A. Lombardo Steroids and steroid-like compounds Clin Sports Med 18 1999 667 689
28. D. Duchaine Underground steroid handbook II 1989 HLR Technical Books Venice (CA)
29. G. Glazer Athrogenic effects of anabolic steroids on serum lipid levels Arch Intern Med 151 1991 1925 1933
30. M.L. Sullivan, C.M. Martinez, and P. Gennis The cardiac toxicity of anabolic steroids Prog Cardiovasc Dis 41 1998 1 5
31. P.J. Turek, R.H. Williams, and J.H. Gilbauch The reversibility of anabolic steroid-induced azospermia J Urol 153 1995 1628 1630
32. J.P. Jarow, and L.I. Lipshultz Anabolic steroid-induced hypogonadotropic hypogonadism Am J Sports Med 18 1990 429 431
33. J.G. MacIndoe, P.J. Perry, and W.R. Yates Testosterone suppression of the HPT axis J Invest Med 45 1997 441 447
34. R.H. Straus, M.T. Liggett, and R.R. Lanese Anabolic steroid use and perceived effects in ten weight-trained women athletes JAMA 253 1985 2871 2873
35. G.N. Conacher, and D.G. Workman Violent crime possibly associated with anabolic steroid use Am J Psychiatry 146 1989 679
36. H.G. Pope Jr., and D.L. Katz Affective and psychotic symptoms associated withanabloic sterod use Am J Psychiatry 145 1988 487 490
37. J. Copeland, R. Peters, and P. Dillon Anabolic-androgenic steroids use disorder among a sample of Australian competitive and recreational users Drug Alcohol Depend 60 2000 91 96
38. S.M. Hewitt, C.K. Smith-Akin, and M.M. Higgins Youth risk behavior surveillance: United States, 1997 MMWR CDC Surveill Summ 47 1998 61
39. M.S. Bahrke, C.E. Yesalis, and A.N. Kopstein Risk factors associated with anabolic = androgenic steroid use among adolescents Sports Med 29 6 2000 397 405
40. C.L. Chng, and A. Moore A study of steroid use among athletes: knolwdge, attitude and use Health Educ 21 6 1990 11 17
41. J.E. Griffin, and J.D. Wilson Disorders of the testes and the male reproductive tract J.D. Wilson D.W. Foster H.M. Kronenberg P.R. Larsen Williams textbook of endocrinology 9th edition 1998 Saunders Philadelphia 819 876
42. A.S. Dobs Is there a role for androgenic anabolic steroids in medical practice? JAMA 281 14 1999 1326 1327
43. U. Suttmann, J. Ockenga, and O. Selberg Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients J Acquir Immune Defic Syndr Hum Retrovirol 8 1995 239 246
44. G.J. Wagner, and J.G. Babkin Testosteron therapy for clinical symptoms of hypogonadism in eugonadal men with AIDS Int J Stud AIDS 9 1998 1 4
45. A. Strawford, T. Bargieri, and M. Van Loan Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial JAMA 28 14 1999 1282 1290
46. A.M. Schols, J. Slangen, and L. Volovics Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1791 1797
47. R. Dolecek, C. Dvoracek, and M. Jezek Very low serum testosterone levels and severe impairment of spermatogenesis in burned male patients. Correlations with basal levels and levels of FSH, LF, and PRL after LHRH + TRH Endocrinol Exp 17 1983 33 45
48. F.D. Moore Response to starvation and stress F.D. Moore Metabolic care of the surgical patient 1959 W.B. Saunders Philadelphia (PA) 202 275
49. T. Newsome, A. Mason, and B. Pruitt Weight loss following thermal injury Ann Sug 178 1973 215 220
50. J.M. Watters, P.Q. Bessey, and C.A. Dinarello Both inflammatrooy and endocrine mediators stimulate host response to sepsis Arch Surg 121 1985 179 182
51. D.W. Wilmore, J.M. Long, and A.D. Mason Jr. Catecholamines: mediator of the hypermetabolidc response to thermal injury Ann Surg 180 1974 653 658
52. D.W. Wilmore, L.H. Aulick, and A.D. Mason Incluence of the burn wound on local and systemic responses to injury Ann Surg 180 1974 653 657
53. D. Wilmore, and I. Aulick Metabolic changes in burned patients Surg Clin North Am 58 1978 1173 1180
54. R. Demling, and L. DeSanti Oxandrolone, an anagolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns J Trauma 43 1 1997 47 51
55. T. Tsilchorozidou, C. Overton, and G. Conway The pathophysiology of polycystic ovary syndrome Clin Endocrinol 60 1 2004 1 17
56. C. Achard, and J. Thiers Le virilisme pilaire et son association a I'insuffisance glucolytique (diaberes des femmes a barb) Bull Acad Natl Med 86 1921 52 64
57. G.A. Burghen, J.R. Givens, and A.E. Kitabchi Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease J Clin Endocrinol Metabol 50 1980 113 116
58. T. Pierpoint, P.M. McKeigue, and A.J. Isaacs Mortality of women with polycystic ovary syndrome at long-term follow-up J Clin Epidemiol 51 1998 582 586